LAMISIL
LAMISIL
Approved
DIN Number
02238703
Drug Class
Human
Market Date
Jan 5, 1999
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02238703
AIG Number0124452001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D01AE15 TERBINAFINE
Product Specifications
Dosage FormSpray
Route of AdministrationTopical
AHFS Classification84:04.08.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
TERBINAFINE HYDROCHLORIDEActive
Strength: 1 % / W/W
Monograph: TERBINAFINE HYDROCHLORIDE